Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Market Cap	24.67B
Revenue (ttm)	6.38B
Net Income (ttm)	1.07B
Shares Out	n/a
EPS (ttm)	3.03
PE Ratio	23.16
Forward PE	n/a
Dividend	1.98 (3.78%)
Ex-Dividend Date	Jun 13, 2024

Volume	5,121,400
Average Volume	604,629
Open	48.50
Previous Close	46.95
Day's Range	48.50 - 55.90
52-Week Range	37.60 - 74.50
Beta	0.26
RSI	45.24
Earnings Date	Mar 29, 2025

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6821

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY